Flagship Pioneering-founded Generate Biomedicines is tacking on a gigantic $273 million in series C funds, though the haul didn't reach the heights of the biotech’s previous $370 million raise back in ...
Flagship Pioneering-backed artificial intelligence start-up Generate:Biomedicines has attracted another big pharma partnership, this time with Novartis. The wide-ranging deal, worth up to $1 billion, ...
Generate Biomedicines, a well-funded startup banking on the promise of artificial intelligence in drug development, filed papers for an initial public offering on Wednesday. Now, it’s looking to take ...
So how does Cambridge, Massachusetts-based Generate program its proteins? It has analyzed the universe of known proteins in nature to learn how they’re made and how they function. The protein analysis ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Generate Biomedicines, whose machine learning-powered Generative Biology platform can rapidly invent new drugs across a wide range of protein modalities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results